Plifosir
View all products
HematologyOncology

Plifosir®

Ibrutinib

Therapeutic area

Antineoplásico. Inhibidor de la BTK — Linfoma de células del manto, leucemia linfocítica crónica, macroglobulinemia de Waldenström.

Presentation

Cápsulas duras de 140 mg.

Pharmacovigilance

We continuously monitor the safety of our products. If you experienced an adverse event, you can report it via this form. Our team will get in touch.

We guarantee quality and effectiveness in every product